BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 8189497)

  • 1. Specific interaction between the bovine papillomavirus E5 transforming protein and the beta receptor for platelet-derived growth factor in stably transformed and acutely transfected cells.
    Petti L; DiMaio D
    J Virol; 1994 Jun; 68(6):3582-92. PubMed ID: 8189497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transformation-specific interaction of the bovine papillomavirus E5 oncoprotein with the platelet-derived growth factor receptor transmembrane domain and the epidermal growth factor receptor cytoplasmic domain.
    Cohen BD; Goldstein DJ; Rutledge L; Vass WC; Lowy DR; Schlegel R; Schiller JT
    J Virol; 1993 Sep; 67(9):5303-11. PubMed ID: 8394451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutational analysis of the interaction between the bovine papillomavirus E5 transforming protein and the endogenous beta receptor for platelet-derived growth factor in mouse C127 cells.
    Nilson LA; Gottlieb RL; Polack GW; DiMaio D
    J Virol; 1995 Sep; 69(9):5869-74. PubMed ID: 7543592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of glutamine 17 of the bovine papillomavirus E5 protein in platelet-derived growth factor beta receptor activation and cell transformation.
    Klein O; Polack GW; Surti T; Kegler-Ebo D; Smith SO; DiMaio D
    J Virol; 1998 Nov; 72(11):8921-32. PubMed ID: 9765437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of amino acids in the transmembrane and juxtamembrane domains of the platelet-derived growth factor receptor required for productive interaction with the bovine papillomavirus E5 protein.
    Petti LM; Reddy V; Smith SO; DiMaio D
    J Virol; 1997 Oct; 71(10):7318-27. PubMed ID: 9311809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stable association between the bovine papillomavirus E5 transforming protein and activated platelet-derived growth factor receptor in transformed mouse cells.
    Petti L; DiMaio D
    Proc Natl Acad Sci U S A; 1992 Aug; 89(15):6736-40. PubMed ID: 1323117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ligand-independent activation of the platelet-derived growth factor beta receptor: requirements for bovine papillomavirus E5-induced mitogenic signaling.
    Drummond-Barbosa D; Vaillancourt RR; Kazlauskas A; DiMaio D
    Mol Cell Biol; 1995 May; 15(5):2570-81. PubMed ID: 7739538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The bovine papillomavirus type 1 E5 transforming protein specifically binds and activates the beta-type receptor for the platelet-derived growth factor but not other related tyrosine kinase-containing receptors to induce cellular transformation.
    Goldstein DJ; Li W; Wang LM; Heidaran MA; Aaronson S; Shinn R; Schlegel R; Pierce JH
    J Virol; 1994 Jul; 68(7):4432-41. PubMed ID: 8207816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An intact PDGF signaling pathway is required for efficient growth transformation of mouse C127 cells by the bovine papillomavirus E5 protein.
    Riese DJ; DiMaio D
    Oncogene; 1995 Apr; 10(7):1431-9. PubMed ID: 7731695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet-derived growth factor receptor can mediate tumorigenic transformation by the bovine papillomavirus E5 protein.
    Nilson LA; DiMaio D
    Mol Cell Biol; 1993 Jul; 13(7):4137-45. PubMed ID: 8321218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bovine papillomavirus E5 protein induces oligomerization and trans-phosphorylation of the platelet-derived growth factor beta receptor.
    Lai CC; Henningson C; DiMaio D
    Proc Natl Acad Sci U S A; 1998 Dec; 95(26):15241-6. PubMed ID: 9860953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The bovine papillomavirus E5 protein requires a juxtamembrane negative charge for activation of the platelet-derived growth factor beta receptor and transformation of C127 cells.
    Klein O; Kegler-Ebo D; Su J; Smith S; DiMaio D
    J Virol; 1999 Apr; 73(4):3264-72. PubMed ID: 10074180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutational analysis of the beta-type platelet-derived growth factor receptor defines the site of interaction with the bovine papillomavirus type 1 E5 transforming protein.
    Staebler A; Pierce JH; Brazinski S; Heidaran MA; Li W; Schlegel R; Goldstein DJ
    J Virol; 1995 Oct; 69(10):6507-17. PubMed ID: 7666552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Compensatory mutants of the bovine papillomavirus E5 protein and the platelet-derived growth factor β receptor reveal a complex direct transmembrane interaction.
    Edwards AP; Xie Y; Bowers L; DiMaio D
    J Virol; 2013 Oct; 87(20):10936-45. PubMed ID: 23926343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Productive interaction between transmembrane mutants of the bovine papillomavirus E5 protein and the platelet-derived growth factor beta receptor.
    Lai CC; Edwards AP; DiMaio D
    J Virol; 2005 Feb; 79(3):1924-9. PubMed ID: 15650217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of the platelet-derived growth factor receptor by the bovine papillomavirus E5 transforming protein.
    Petti L; Nilson LA; DiMaio D
    EMBO J; 1991 Apr; 10(4):845-55. PubMed ID: 1849073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. E5 oncoprotein transmembrane mutants dissociate fibroblast transforming activity from 16-kilodalton protein binding and platelet-derived growth factor receptor binding and phosphorylation.
    Sparkowski J; Mense M; Anders J; Schlegel R
    J Virol; 1996 Apr; 70(4):2420-30. PubMed ID: 8642670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A single amino acid substitution converts a transmembrane protein activator of the platelet-derived growth factor β receptor into an inhibitor.
    Petti LM; Talbert-Slagle K; Hochstrasser ML; DiMaio D
    J Biol Chem; 2013 Sep; 288(38):27273-27286. PubMed ID: 23908351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The E5 protein of HPV-6, but not HPV-16, associates efficiently with cellular growth factor receptors.
    Conrad M; Goldstein D; Andresson T; Schlegel R
    Virology; 1994 May; 200(2):796-800. PubMed ID: 7909971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The transmembrane domain of the E5 oncoprotein contains functionally discrete helical faces.
    Adduci AJ; Schlegel R
    J Biol Chem; 1999 Apr; 274(15):10249-58. PubMed ID: 10187811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.